Debora Sobral (Formerly Araujo)

Founder and CEO, ClinBiz

Débora Sobral (Formerly Araujo) has over seventeen years of experience in the pharmaceutical industry working and consulting for Fortune 500 companies. During her time in this industry her special focus has been on the business aspects of clinical trials including: clinical contracting and financial management, clinical outsourcing and CRO/vendor management, global clinical trial budgeting and forecasting, clinical financial analytics and metrics/KPIs, site budget development and negotiations, Fair Market Value (FMV) and global investigator site payments. She has also utilized her expertise and knowledge to drive practical change in this industry via thought leadership material, conference presentations and consulting engagements.

Débora’s passion for driving practical change in the industry led her to launch ClinBiz (www.clinbiz.com), an online platform where clinical research professionals can stay connected and updated on the latest topics, trends and technologies related to the business aspects of clinical trials.  Débora is also author of the practical guide book on clinical trial agreement negotiations named ‘The Four Villains of Clinical Trial Agreement Delays and How To Defeat Them’ which quickly became an Amazon’s #1 New Release in the pharmaceutical and biotechnology category.

Débora is also a passionate entrepreneur expressing this passion via diverse ventures and projects.

My Sessions

Conference Host

All Things Clinical Site Contracts/Budgets, Fair Market Value and Site Payments

Close of Day 3

Welcome Day 2

Close of Day 2

Welcome Day 1

Clinical Business Operations Topics – Panel Discussion

Exact topic to be determined in final agenda within the below parameters: • Clinical/site contracts • Study and site budgets • Site payments • FMV • Benchmarking •Investigator Initiated Studies (IIS) • Confidentiality agreements • Contract negotiations and timelines • Clinical outsourcing • Clinical business operations • Clinical operations (top pain points) • Feasibility • Vendor management • Innovative clinical trial technologies • Latest best practices


Welcome Day 3